Highly potent intracellular membrane-associated Aβ seeds

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Alzheimer's disease (AD) pathogenesis involves amyloid-beta (Aβ) peptide aggregation.
• Prion-like seeding is a proposed mechanism for Aβ aggregate formation.
• The precise molecular nature and location of Aβ seeds remain unclear.

Purpose of the Study:

• To investigate the presence and role of Aβ seeds in membrane fractions.
• To determine if membrane-associated Aβ seeds can initiate and propagate aggregation.
• To explore the implications of intracellular Aβ seeds in AD.

Main Methods:

• Separation and immunoisolation of membrane fractions from amyloid-laden brain homogenates.
• Assay of Aβ seeding activity in membrane fractions.
• In vitro and in vivo studies to assess the aggregation-inducing capacity of membrane-associated seeds.

Main Results:

• Significant Aβ seeding activity was detected in membrane fractions, independent of detectable amyloid fibrils.
• Aβ seeds associated with mitochondrial or related membranes effectively induced Aβ aggregation in vitro.
• These membrane-bound seeds were capable of initiating β-amyloidosis in vivo.

Conclusions:

• Membrane-associated Aβ seeds are a key component in early Alzheimer's disease pathogenesis.
• Intracellular membrane-bound Aβ seeds may facilitate the spread of aggregation and downstream pathologies.
• Targeting these membrane-associated seeds could offer novel therapeutic strategies for Alzheimer's disease.